{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T18:54:59Z","timestamp":1766516099525,"version":"build-2065373602"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Laboratory Medicine"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.cll.2025.01.009","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T08:29:38Z","timestamp":1741681778000},"page":"259-269","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Interpreting Toxicology Results in Perinatal and Newborn Specimens"],"prefix":"10.1016","volume":"45","author":[{"given":"Emily Lu","family":"Ryan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.cll.2025.01.009_bib1","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1097\/01.AOG.0000466371.86393.9b","article-title":"Committee opinion no. 633: alcohol abuse and other substance use disorders: ethical issues in obstetric and gynecologic practice","volume":"125","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.cll.2025.01.009_bib2","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1097\/AOG.0000000000002235","article-title":"Committee Opinion No. 711: opioid use and opioid use disorder in pregnancy","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.cll.2025.01.009_bib3","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1373\/jalm.2017.023341","article-title":"Executive summary: American association of clinical chemistry laboratory medicine practice guideline-using clinical laboratory tests to monitor drug therapy in pain management patients","volume":"2","author":"Jannetto","year":"2018","journal-title":"J Appl Lab Med"},{"issue":"3","key":"10.1016\/j.cll.2025.01.009_bib4","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/AOG.0000000000003986","article-title":"Toxicology testing in pregnancy: evaluating the role of social profiling","volume":"136","author":"Perlman","year":"2020","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.cll.2025.01.009_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajogmf.2022.100733","article-title":"Urine drug screening on labor and delivery","volume":"4","author":"Chin","year":"2022","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"3","key":"10.1016\/j.cll.2025.01.009_bib6","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jpeds.2014.10.004","article-title":"Universal maternal drug testing in a high-prevalence region of prescription opiate abuse","volume":"166","author":"Wexelblatt","year":"2015","journal-title":"J Pediatr"},{"issue":"8","key":"10.1016\/j.cll.2025.01.009_bib7","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/s41372-022-01335-3","article-title":"Rates of substance and polysubstance use through universal maternal testing at the time of delivery","volume":"42","author":"Smith","year":"2022","journal-title":"J Perinatol"},{"issue":"8","key":"10.1016\/j.cll.2025.01.009_bib8","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/jat\/bkaa027","article-title":"Assessment of tobacco exposure during pregnancy by meconium analysis and maternal interview","volume":"44","author":"L\u00f3pez-Rabu\u00f1al","year":"2020","journal-title":"J Anal Toxicol"},{"issue":"5","key":"10.1016\/j.cll.2025.01.009_bib9","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/jp.2010.132","article-title":"Agreement of umbilical cord drug and cotinine levels with maternal self-report of drug use and smoking during pregnancy","volume":"31","author":"Wright","year":"2011","journal-title":"J Perinatol"},{"issue":"1","key":"10.1016\/j.cll.2025.01.009_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/bmjpo-2019-000482","article-title":"In vitro validation of a method for neonatal urine collection and analysis","volume":"3","author":"Ritchie","year":"2019","journal-title":"BMJ Paediatr Open"},{"key":"10.1016\/j.cll.2025.01.009_bib11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ebiom.2017.12.016","article-title":"Development of the human fetal kidney from mid to late gestation in male and female infants","volume":"27","author":"Ryan","year":"2018","journal-title":"EBioMedicine"},{"issue":"4","key":"10.1016\/j.cll.2025.01.009_bib12","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1093\/jalm\/jfaa027","article-title":"Rates of fentanyl positivity in neonatal urine following maternal analgesia during labor and delivery","volume":"5","author":"Novikov","year":"2020","journal-title":"J Appl Lab Med"},{"issue":"4","key":"10.1016\/j.cll.2025.01.009_bib13","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1373\/jalm.2016.021162","article-title":"Is this drug screen really negative? Special investigation of drug screening in pediatrics","volume":"1","author":"Pyle-Eilola","year":"2017","journal-title":"J Appl Lab Med"},{"issue":"2","key":"10.1016\/j.cll.2025.01.009_bib14","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/jalm\/jfab157","article-title":"Development and implementation of one-step, broad-spectrum, high-sensitivity drug screening by tandem mass spectrometry in a pediatric population","volume":"7","author":"Tesfazghi","year":"2022","journal-title":"J Appl Lab Med"},{"issue":"1","key":"10.1016\/j.cll.2025.01.009_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jat\/bkw112","article-title":"Optimization and validation of high-resolution mass spectrometry data analysis parameters","volume":"41","author":"Colby","year":"2017","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.cll.2025.01.009_bib16","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.clinbiochem.2021.05.004","article-title":"Urine toxicology screening by liquid chromatography time-of-flight mass spectrometry in a quaternary hospital setting","volume":"95","author":"Pope","year":"2021","journal-title":"Clin Biochem"},{"key":"10.1016\/j.cll.2025.01.009_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1111601","article-title":"Drug exposure during pregnancy: current understanding and approaches to measure maternal-fetal drug exposure","volume":"14","author":"Hudson","year":"2023","journal-title":"Front Pharmacol"},{"issue":"4","key":"10.1016\/j.cll.2025.01.009_bib18","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3390\/toxins14040278","article-title":"Cocaine: an updated overview on chemistry, detection, biokinetics, and pharmacotoxicological aspects including abuse pattern","volume":"14","author":"Roque Bravo","year":"2022","journal-title":"Toxins"},{"issue":"3","key":"10.1016\/j.cll.2025.01.009_bib19","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/jat\/bkx097","article-title":"Quantitation of cocaine and metabolites, phencyclidine, butalbital and phenobarbital in meconium by liquid chromatography-tandem mass spectrometry","volume":"42","author":"Scroggin","year":"2018","journal-title":"J Anal Toxicol"},{"issue":"7","key":"10.1016\/j.cll.2025.01.009_bib20","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/clinchem\/hvaa113","article-title":"Identifying and quantifying cannabinoids in biological matrices in the medical and legal cannabis era","volume":"66","author":"Karschner","year":"2020","journal-title":"Clin Chem"},{"key":"10.1016\/j.cll.2025.01.009_bib21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.clinms.2019.01.002","article-title":"Detection of in utero exposure to cannabis in paired umbilical cord tissue and meconium by liquid chromatography-tandem mass spectrometry","volume":"14 Pt B","author":"Jensen","year":"2019","journal-title":"Clin Mass Spectrom"},{"issue":"3","key":"10.1016\/j.cll.2025.01.009_bib22","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/jat\/bkw113","article-title":"Stability of 21 cocaine, opioid and benzodiazepine drug analytes in spiked meconium at three temperatures","volume":"41","author":"Wu","year":"2017","journal-title":"J Anal Toxicol"},{"issue":"8","key":"10.1016\/j.cll.2025.01.009_bib23","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1542\/hpeds.2018-0227","article-title":"Increased severity of neonatal abstinence syndrome associated with concomitant antenatal opioid and benzodiazepine exposure","volume":"9","author":"Sanlorenzo","year":"2019","journal-title":"Hosp Pediatr"},{"key":"10.1016\/j.cll.2025.01.009_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2023.109872","article-title":"Polysubstance use during pregnancy: the importance of screening, patient education, and integrating a harm reduction perspective","volume":"247","author":"Board","year":"2023","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"10.1016\/j.cll.2025.01.009_bib25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/jat\/33.3.177","article-title":"Evaluation of a new ELISA kit for the detection of benzodiazepines in meconium","volume":"33","author":"Marin","year":"2009","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.cll.2025.01.009_bib26","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/1471-2393-14-250","article-title":"Retrospective analysis of the diagnostic yield of newborn drug testing","volume":"14","author":"Wood","year":"2014","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.cll.2025.01.009_bib27","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jpeds.2018.09.046","article-title":"Umbilical cord tissue and meconium may not Be equivalent for confirming in utero substance exposure","volume":"205","author":"Colby","year":"2019","journal-title":"J Pediatr"},{"issue":"6","key":"10.1016\/j.cll.2025.01.009_bib28","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/jat\/bkad024","article-title":"Longitudinal trends in meconium drug detection in 46 US states between the years 2015 and 2020","volume":"47","author":"Pandya","year":"2023","journal-title":"J Anal Toxicol"},{"issue":"1","key":"10.1016\/j.cll.2025.01.009_bib29","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/jalm\/jfaa196","article-title":"Drug positivity findings from a universal umbilical cord tissue drug analysis program in appalachia","volume":"6","author":"Yossuck","year":"2021","journal-title":"J Appl Lab Med"},{"issue":"18","key":"10.1016\/j.cll.2025.01.009_bib30","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.clinbiochem.2017.09.016","article-title":"Method performance and clinical workflow outcomes associated with meconium and umbilical cord toxicology testing","volume":"50","author":"Labardee","year":"2017","journal-title":"Clin Biochem"},{"issue":"1","key":"10.1016\/j.cll.2025.01.009_bib31","doi-asserted-by":"crossref","DOI":"10.1080\/14767058.2023.2211706","article-title":"Can umbilical cord testing add to maternal urine drug screen for evaluation of infants at risk of neonatal opioid withdrawal syndrome?","volume":"36","author":"Gersch","year":"2023","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"1","key":"10.1016\/j.cll.2025.01.009_bib32","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/jat\/bkac037","article-title":"Can umbilical cord and meconium results Be directly compared? Analytical approach matters","volume":"47","author":"Pandya","year":"2023","journal-title":"J Anal Toxicol"},{"issue":"21","key":"10.1016\/j.cll.2025.01.009_bib33","doi-asserted-by":"crossref","first-page":"5493","DOI":"10.1007\/s00216-021-03533-y","article-title":"Simultaneous determination of 137 drugs of abuse, new psychoactive substances, and novel synthetic opioids in meconium by UHPLC-QTOF","volume":"413","author":"L\u00f3pez-Rabu\u00f1al","year":"2021","journal-title":"Anal Bioanal Chem"},{"issue":"2","key":"10.1016\/j.cll.2025.01.009_bib34","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3390\/toxics10020055","article-title":"Determination of prenatal substance exposure using meconium and orbitrap mass spectrometry","volume":"10","author":"Hernandez","year":"2022","journal-title":"Toxics"},{"key":"10.1016\/j.cll.2025.01.009_bib35","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jpeds.2019.09.029","article-title":"Identifying Co-exposure to opiates and gabapentin during pregnancy","volume":"217","author":"Loudin","year":"2020","journal-title":"J Pediatr"},{"issue":"7","key":"10.1016\/j.cll.2025.01.009_bib36","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/add.13324","article-title":"Gabapentin misuse, abuse and diversion: a systematic review","volume":"111","author":"Smith","year":"2016","journal-title":"Addiction"},{"issue":"5","key":"10.1016\/j.cll.2025.01.009_bib37","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/jat\/bkaa118","article-title":"Patterns of neonatal Co-exposure to gabapentin and commonly abused drugs observed in umbilical cord tissue","volume":"45","author":"Okoye","year":"2021","journal-title":"J Anal Toxicol"},{"issue":"1","key":"10.1016\/j.cll.2025.01.009_bib38","first-page":"36","article-title":"Characterization of an amphetamine interference from gabapentin in an LC-HRMS method","volume":"44","author":"Mu\u00f1oz-Mu\u00f1oz","year":"2020","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.cll.2025.01.009_bib39","article-title":"Health effects associated with kratom (mitragyna speciosa) and polysubstance use: a narrative review","volume":"16","author":"Striley","year":"2022","journal-title":"Subst Abuse"},{"issue":"6","key":"10.1016\/j.cll.2025.01.009_bib40","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-1839","article-title":"Neonatal abstinence syndrome due to maternal kratom use","volume":"142","author":"Eldridge","year":"2018","journal-title":"Pediatrics"},{"issue":"9","key":"10.1016\/j.cll.2025.01.009_bib41","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1093\/jat\/bkac064","article-title":"Analysis of mitragynine and speciociliatine in umbilical cord by LC-MS-MS for detecting prenatal exposure to kratom","volume":"46","author":"Hughs","year":"2023","journal-title":"J Anal Toxicol"},{"issue":"8","key":"10.1016\/j.cll.2025.01.009_bib42","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1093\/jat\/bkab055","article-title":"Neonatal exposure to tramadol through mother\u2019s breast milk","volume":"45","author":"Gesseck","year":"2021","journal-title":"J Anal Toxicol"},{"issue":"4","key":"10.1016\/j.cll.2025.01.009_bib43","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/jalm\/jfac009","article-title":"Bupivacaine metabolite can interfere with norfentanyl measurement by LC-MS\/MS","volume":"7","author":"Mahowald","year":"2022","journal-title":"J Appl Lab Med"},{"issue":"7","key":"10.1016\/j.cll.2025.01.009_bib44","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/jat\/bku061","article-title":"Meconium drug testing in multiple births in the USA","volume":"38","author":"Wood","year":"2014","journal-title":"J Anal Toxicol"},{"issue":"6","key":"10.1016\/j.cll.2025.01.009_bib45","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/jat\/bkab077","article-title":"Concordance of umbilical cord drug screening in multiple births: experience from a reference laboratory and academic medical center","volume":"46","author":"Nelson","year":"2022","journal-title":"J Anal Toxicol"},{"issue":"6","key":"10.1016\/j.cll.2025.01.009_bib46","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.3390\/jcm12062175","article-title":"Perinatal psychoactive substances use: a rising perinatal mental health concern","volume":"12","author":"ELNahas","year":"2023","journal-title":"J Clin Med"}],"container-title":["Clinics in Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271225000101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271225000101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T18:22:27Z","timestamp":1762280547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272271225000101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0272271225000101"],"URL":"https:\/\/doi.org\/10.1016\/j.cll.2025.01.009","relation":{},"ISSN":["0272-2712"],"issn-type":[{"type":"print","value":"0272-2712"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interpreting Toxicology Results in Perinatal and Newborn Specimens","name":"articletitle","label":"Article Title"},{"value":"Clinics in Laboratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cll.2025.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}